Share

Global Disease Challenges

hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.

Global Disease Challenges

expand

Our Aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.

5-Year Target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.

Status: Exceeded

Our Impact:

• How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

• Working to Make HIV History

• Our Mission: Enabling a World Without TB

Related Content

Johnson & Johnson's COVID-19 Vaccine

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

New Pediatric Formulation of Janssen’s Treatment for Intestinal Worms Achieves World Health Organization Prequalification

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

“I Was on the Ground During the HIV Epidemic": Meet the Scientist Who's Sharing the Spotlight With Celebs at the Global Citizen Festival

Dr. Paul Stoffels, Johnson & Johnson Chief Scientific Officer, at 2017 Global Citizen Festival

Ending MDR-TB: “It’s Doable. Let’s Solve It”

Ending MDR-TB: “It’s Doable. Let’s Solve It”

The Global Fund, Stop TB, The Economist and WEF joined Johnson & Johnson in the coLaboratory for the Future

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

The New Ebola Clinical Trial That's Focused on Helping Halt Future Outbreaks

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Unseen Enemy: The New Film That Looks at Why Viruses Like Zika, Ebola and Influenza Are So Prevalent

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

Johnson & Johnson Teams Up With Health Officials Across Brazil to Fight Zika

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

The Janssen Pharmaceutical Companies of Johnson & Johnson Partner on an Ambitious Tuberculosis Program in India

Our 2030 Promise

Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.

Learn More About Our SDG Commitment

More From Johnson & Johnson

Latest News

Johnson & Johnson Named to the TIME100 Most Influential Companies List

Johnson & Johnson Named to the TIME100 Most Influential Companies List

The company is honored to be recognized for its leadership in helping shape the trajectory of healthcare around the world.

Innovation

Quiz: How Much Do You Really Know About COVID-19?

Quiz: How Much Do You Really Know About COVID-19?

Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge.

Virus graphic

Latest News

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.